Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 130,524 | 151,890 | 159,767 | 133,791 | 141,919 |
| Cost of Goods | 1,343 | 3,686 | 1,515 | 4,745 | 4,170 |
| Gross Profit | 129,181 | 148,204 | 158,252 | 129,046 | 137,749 |
| Operating Expenses | 243,672 | 356,909 | 217,921 | 215,305 | 195,423 |
| Operating Income | -114,148 | -208,019 | -59,154 | -85,514 | -57,504 |
| Interest Expense | 17,123 | 1,731 | 2,139 | 2,130 | 2,122 |
| Other Income | 18,328 | 165,420 | 14,584 | -15,231 | -4,445 |
| Pre-tax Income | -112,943 | -44,330 | -46,709 | -102,875 | -64,071 |
| Income Tax | 11,380 | 8,100 | 283 | 2,260 | 1,094 |
| Net Income Continuous | -124,323 | -52,430 | -46,992 | -105,135 | -65,165 |
| Net Income | $-124,323 | $-52,430 | $-46,992 | $-105,135 | $-65,165 |
| EPS Basic Total Ops | -0.87 | -0.37 | -0.33 | -0.74 | -0.46 |
| EPS Basic Continuous Ops | -0.87 | -0.37 | -0.33 | -0.74 | -0.46 |
| EPS Diluted Total Ops | -0.87 | -0.37 | -0.33 | -0.74 | -0.46 |
| EPS Diluted Continuous Ops | -0.87 | -0.37 | -0.33 | -0.74 | -0.46 |
| EBITDA(a) | $-112,098 | $-201,335 | $-51,507 | $-75,391 | $-47,091 |